ReviewCancers2025
Molecular Pathways and Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL).
Jonathan Weiss et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewCancers2025
Jonathan Weiss et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.